You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 252 No. 21, December 7, 1984 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Males Exposed In Utero to Diethylstilbestrol

Frank J. Leary, MD; Laurence J. Resseguie, PhD; Leonard T. Kurland, MD; Peter C. O'Brien, PhD; Richard F. Emslander, MD; Kenneth L. Noller, MD

JAMA. 1984;252(21):2984-2989.


Abstract

An increased frequency of various genitourinary anomalies, infertility, and testicular cancer among males has been reported to follow intrauterine exposure to diethylstilbestrol, but not all studies have confirmed an association. This study was designed to determine whether a cohort of males exposed in utero to diethylstilbestrol had a higher frequency of urogenital abnormalities than an unexposed cohort. Biases in selection of exposed and control participants were minimized. Of 828 exposed and 676 control men studied by medical-record review, 265 exposed men and 274 controls also underwent a special clinical examination. Overall, the data suggest that diethylstilbestrol exposure of males in utero did not increase their risk of genitourinary abnormalities, infertility, or testicular cancer. Previously reported increased frequencies of these abnormalities in diethylstilbestrol-exposed men may have resulted from selection biases or differences in diethylstilbestrol use, or both.

(JAMA 1984;252:2984-2989)



Author Affiliations

From the Departments of Urology (Dr Leary), Medical Statistics and Epidemiology (Drs Resseguie, Kurland, and O'Brien), Internal Medicine (Endocrinology) (Dr Emslander), and Obstetrics and Gynecology (Dr Noller), Mayo Clinic and Mayo Foundation, Rochester, Minn.


Footnotes

Reprint requests to Mayo Clinic, 200 First St SW, Rochester, MN 55905 (Dr Leary).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Time to Pregnancy and Secondary Sex Ratio in Men Exposed Prenatally to Diethylstilbestrol
Wise et al.
Am J Epidemiol 2007;166:765-774.
ABSTRACT | FULL TEXT  

Developmental Changes in Testicular Sensitivity to Estrogens throughout Fetal and Neonatal Life
Delbes et al.
Toxicol Sci 2007;99:234-243.
ABSTRACT | FULL TEXT  

Mechanisms of Estrogen Action
Nilsson et al.
Physiol. Rev. 2001;81:1535-1565.
ABSTRACT | FULL TEXT  

Cancer Risk in Men Exposed In Utero to Diethylstilbestrol
Strohsnitter et al.
JNCI J Natl Cancer Inst 2001;93:545-551.
ABSTRACT | FULL TEXT  

Exposure to Diethylstilbestrol: Design of a Multilevel Community Intervention
Duke et al.
Health Promot Pract 2000;1:188-195.
ABSTRACT  

Fertility in Men Exposed Prenatally to Diethylstilbestrol
Wilcox et al.
NEJM 1995;332:1411-1416.
ABSTRACT | FULL TEXT  

Significance of Leydig Cell Neoplasia in Rats Fed Lactitol or Lactose
Bar
International Journal of Toxicology 1992;11:189-207.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.